ClinicalTrials.Veeva

Menu

Risk and Incidence of Aortic Graft and Endograft Infection With BSI

L

Lund University

Status

Enrolling

Conditions

Aortic Infections and Inflammations

Study type

Observational

Funder types

Other

Identifiers

NCT05521035
2022-5-BSI

Details and patient eligibility

About

What is the risk of aortic vascular graft and endograft infection in patients with aortic vascular graft/endograft and bloodstream infection?

Full description

All patients with previous aortic vascular graft and endograft surgery between years 2010 and 2021 in four regions of south Sweden (Skåne, Halland, Kronoberg and Blekinge) will be included in the study. These patients will be evaluated for bloodstream infection (BSI) or not. For all patients with BSI, the risk of aortic vascular graft and endograft infection will be investigated. Aortic vascular graft and endograft infection will be determined by usage of the MAGIC-criteria.

Risk factors for developing aortic vascular graft and endograft infection will be investigated, and if possible used to construct a risk score. This risk score could be used by clinicians to determine if bacteremic patients with aortic vascular grafts or endografts should be evaluated for aortic vascular graft and endograft infection.

Enrollment

2,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Previous aortic vascular graft or endograft infection with bloodstream infection.

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Oskar Ljungquist, M.D, PhD; Torgny Sunnerhagen, M.D, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems